JP2008537482A5 - - Google Patents

Download PDF

Info

Publication number
JP2008537482A5
JP2008537482A5 JP2008501054A JP2008501054A JP2008537482A5 JP 2008537482 A5 JP2008537482 A5 JP 2008537482A5 JP 2008501054 A JP2008501054 A JP 2008501054A JP 2008501054 A JP2008501054 A JP 2008501054A JP 2008537482 A5 JP2008537482 A5 JP 2008537482A5
Authority
JP
Japan
Prior art keywords
amino acid
protein
nucleic acid
virus
acid substitution
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2008501054A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008537482A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2006/009010 external-priority patent/WO2006099360A2/en
Publication of JP2008537482A publication Critical patent/JP2008537482A/ja
Publication of JP2008537482A5 publication Critical patent/JP2008537482A5/ja
Pending legal-status Critical Current

Links

JP2008501054A 2005-03-10 2006-03-09 メタニューモウイルス株、およびワクチン製剤におけるその使用および抗原配列発現用ベクターとしてのその使用、ならびにウイルスの増殖法 Pending JP2008537482A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US66073505P 2005-03-10 2005-03-10
PCT/US2006/009010 WO2006099360A2 (en) 2005-03-10 2006-03-09 Metapneumovirus strains and their use in vaccine formulations and as vectors for expression of antigenic sequences and methods for propagating virus

Publications (2)

Publication Number Publication Date
JP2008537482A JP2008537482A (ja) 2008-09-18
JP2008537482A5 true JP2008537482A5 (enExample) 2009-04-30

Family

ID=36992353

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2008501054A Pending JP2008537482A (ja) 2005-03-10 2006-03-09 メタニューモウイルス株、およびワクチン製剤におけるその使用および抗原配列発現用ベクターとしてのその使用、ならびにウイルスの増殖法

Country Status (8)

Country Link
US (2) US20060216700A1 (enExample)
EP (1) EP1869225A4 (enExample)
JP (1) JP2008537482A (enExample)
KR (1) KR20070110924A (enExample)
CN (1) CN101548009A (enExample)
AU (1) AU2006223138B2 (enExample)
CA (1) CA2600484A1 (enExample)
WO (1) WO2006099360A2 (enExample)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040096451A1 (en) * 2002-07-25 2004-05-20 Young James F. Methods of treating and preventing RSV, hMPV, and PIV using anti-RSV, anti-hMPV, and anti-PIV antibodies
US8715922B2 (en) * 2001-01-19 2014-05-06 ViroNovative Virus causing respiratory tract illness in susceptible mammals
DK1351981T3 (da) 2001-01-19 2012-11-26 Vironovative Bv Et virus, der forårsager luftvejssygdom hos modtagelige pattedyr
TWI344991B (en) 2002-02-21 2011-07-11 Medimmune Vaccines Inc Metapneumovirus strains as vaccine formulations and as vectors for expression of heterologous antigenic sequences
US20080213749A1 (en) * 2007-03-02 2008-09-04 Melanie Feola Compositions and methods for detecting human metapneumovirus
US20090017517A1 (en) * 2007-07-13 2009-01-15 Medimmune, Llc Preparation of Negative-Stranded RNA Viruses by Electroporation
WO2009062532A1 (en) * 2007-11-16 2009-05-22 Vironovative Bv Live attenuated metapneumovirus strains and their use in vaccine formulations and chimeric metapneumovirus strains
US20090186050A1 (en) * 2007-11-16 2009-07-23 Fouchier Ron A M Live attenuated metapneumovirus strains and their use in vaccine formulations and chimeric metapneumovirus strains
GB0809881D0 (en) * 2008-05-30 2008-07-09 Genomica Sau Method for detecting respiratory viral agents in a test sample
ES2987238T3 (es) 2008-12-09 2024-11-14 Novavax Inc Proteínas F del RSV modificadas y métodos de su uso
EP2453903B1 (en) * 2009-07-17 2016-08-17 Industry Academic Cooperation Foundation, Hallym University Immunostimulatory compositions comprising liposome-encapsulated oligonucleotides and epitopes
EP4421177A3 (en) 2013-03-13 2024-12-18 The United States of America, as represented by the Secretary, Department of Health and Human Services Prefusion rsv f proteins and their use
CL2014003373A1 (es) * 2014-12-11 2015-04-10 Univ Pontificia Catolica Chile Anticuerpos monoclonales especificos para el antígeno m del virus metapneumovirus humano (hmpv), producidos y secretados por hibridomas celulares , útiles para la deteccion y el diagnostico de la infeccion causada por hmpv.
CN115960263A (zh) 2016-03-29 2023-04-14 美国政府(由卫生和人类服务部的部长所代表) 取代修饰的融合前rsv f蛋白及其用途
CN106282407A (zh) * 2016-08-11 2017-01-04 青岛易邦生物工程有限公司 一种b亚群禽肺病毒疫苗的效检方法
WO2018109220A2 (en) 2016-12-16 2018-06-21 Institute For Research In Biomedicine Novel recombinant prefusion rsv f proteins and uses thereof
CN109628413A (zh) * 2018-12-29 2019-04-16 广东和信健康科技有限公司 一种人偏肺病毒的培养方法及其产物和应用
CN120022355A (zh) * 2023-11-22 2025-05-23 长春百克生物科技股份公司 一种mRNA疫苗及其应用
CN120608026B (zh) * 2025-05-21 2026-05-01 广州国家实验室 一种人类偏肺病毒鼠适应株及其应用
CN120866573A (zh) * 2025-06-26 2025-10-31 温氏食品集团股份有限公司 一种基于纳米孔测序的番鸭c型偏肺病毒全基因组测序方法
CN121086052B (zh) * 2025-09-04 2026-07-07 上海申锐联生物医药有限公司 一种棘球蚴Eg95蛋白、编码该蛋白的核苷酸及mRNA

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5166057A (en) * 1989-08-28 1992-11-24 The Mount Sinai School Of Medicine Of The City University Of New York Recombinant negative strand rna virus expression-systems
US5824307A (en) * 1991-12-23 1998-10-20 Medimmune, Inc. Human-murine chimeric antibodies against respiratory syncytial virus
EP0780475B2 (en) 1995-08-09 2006-07-19 SCHWEIZ. SERUM- & IMPFINSTITUT BERN Process for the production of infectious negative-strand RNA viruses
US5869036A (en) * 1995-12-08 1999-02-09 St. Louis University Live attenuated vaccines based on CP45 HPIV-3 strain and method to ensure attenuation in such vaccine
US6180398B1 (en) * 1996-07-12 2001-01-30 Virogeneitics Corporation Two-step immunization procedure against the pyramyxoviridae family of viruses using recombinant virus and subunit protein preparation
US7192593B2 (en) * 1997-05-23 2007-03-20 The United States Of America, Represented By The Secretary, Department Of Health And Human Services Use of recombinant parainfluenza viruses (PIVs) as vectors to protect against infection and disease caused by PIV and other human pathogens
US6146642A (en) * 1998-09-14 2000-11-14 Mount Sinai School Of Medicine, Of The City University Of New York Recombinant new castle disease virus RNA expression systems and vaccines
US20020019891A1 (en) * 1999-12-30 2002-02-14 James Morrow Generic device controller unit and method
JP2002025374A (ja) 2000-07-07 2002-01-25 Matsushita Electric Ind Co Ltd Ｅｌシート及びこれを用いたスイッチ
DK1351981T3 (da) * 2001-01-19 2012-11-26 Vironovative Bv Et virus, der forårsager luftvejssygdom hos modtagelige pattedyr
US8715922B2 (en) * 2001-01-19 2014-05-06 ViroNovative Virus causing respiratory tract illness in susceptible mammals
US20030232061A1 (en) * 2001-10-18 2003-12-18 Fouchier Ronaldus Adrianus Maria Recombinant parainfluenza virus expression systems and vaccines comprising heterologous antigens derived from metapneumovirus
TWI344991B (en) * 2002-02-21 2011-07-11 Medimmune Vaccines Inc Metapneumovirus strains as vaccine formulations and as vectors for expression of heterologous antigenic sequences
KR20050100379A (ko) * 2003-01-31 2005-10-18 가부시키가이샤 디나벡크 겐큐쇼 리보자임을 코드하는 파라믹소바이러스 벡터 및 그의 이용
JP2007524372A (ja) * 2003-02-28 2007-08-30 ザ ガバメント オブ ザ ユナイテッド ステイツ オブ アメリカ アズ リプレゼンテッド バイ ザ セクレタリー オブ ザ デパートメント オブ ヘルス アンド ヒューマン サービシーズ 組換えヒトメタニューモウイルスおよびその使用
CA2523657A1 (en) * 2003-04-25 2005-03-31 Medimmune Vaccines, Inc. Recombinant parainfluenza virus expression systems and vaccines comprising heterologous antigens derived from metapneumovirus
CN101410519B (zh) * 2003-04-25 2013-04-24 免疫医疗有限责任公司 间质肺病毒株及其在疫苗制剂中以及用作抗原性序列表达载体的用途和繁殖病毒的方法
WO2005007078A2 (en) * 2003-04-30 2005-01-27 The Boards Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Method of inhibiting human metapneumovirus and human coronavirus in the prevention and treatment of severe acute respiratory syndrome (sars)

Similar Documents

Publication Publication Date Title
Steward et al. RNA editing in Newcastle disease virus
St-Jean et al. Human respiratory coronavirus OC43: genetic stability and neuroinvasion
Meyer et al. Endogenous retroviruses: with us and against us
Stobart et al. Chimeric exchange of coronavirus nsp5 proteases (3CLpro) identifies common and divergent regulatory determinants of protease activity
Harris et al. Interaction of poliovirus polypeptide 3CDpro with the 5 ‘and 3 ‘termini of the poliovirus genome. Identification of viral and cellular cofactors needed for efficient binding.
Shiura et al. PEG10 viral aspartic protease domain is essential for the maintenance of fetal capillary structure in the mouse placenta
Pyrc et al. Genome structure and transcriptional regulation of human coronavirus NL63
Nedialkova et al. Biochemical characterization of arterivirus nonstructural protein 11 reveals the nidovirus-wide conservation of a replicative endoribonuclease
Ziebuhr et al. Human coronavirus 229E papain-like proteases have overlapping specificities but distinct functions in viral replication
Garvin et al. Potentially adaptive SARS-CoV-2 mutations discovered with novel spatiotemporal and explainable AI models
Perera et al. Alphavirus nucleocapsid protein contains a putative coiled coil α-helix important for core assembly
Wang et al. Alanine scanning of poliovirus 2CATPase reveals new genetic evidence that capsid protein/2CATPase interactions are essential for morphogenesis
Herold et al. Proteolytic processing at the amino terminus of human coronavirus 229E gene 1-encoded polyproteins: identification of a papain-like proteinase and its substrate
ATE478944T1 (de) Zytokin ligand zur behandlung von asthma und atemwegsüberreaktivität
JP2006149395A5 (enExample)
Mangel et al. Specific interactions of the adenovirus proteinase with the viral DNA, an 11-amino-acid viral peptide, and the cellular protein actin
York et al. Genetic analysis of heptad-repeat regions in the G2 fusion subunit of the Junin arenavirus envelope glycoprotein
DE602004031642D1 (de) Methode zur verbesserung der wirksamkeit von biologischen antwort-verändernden proteinen und exemplarische muteine
GB2409274A (en) Trap-tagging: a novel method for the identification and purification of RNA-protein complexes
Chow et al. Adenovirus-mediated expression of the C-terminal domain of SARS-CoV spike protein is sufficient to induce apoptosis in Vero E6 cells
Barretto et al. Deubiquitinating activity of the SARS-CoV papain-like protease
Lu et al. Spike gene deletion quasispecies in serum of patient with acute MERS‐CoV infection
JP2006042820A5 (enExample)
WO2006038129A3 (en) Hepatitis c virus replication system
Chen et al. Identification of the critical residues of TMPRSS2 for entry and host range of human coronavirus HKU1